[Molvis-list] New speakers added: ChemAxon's 2009 US User Group Meeting: September 15-16, San Diego, CA
Alex Allardyce
aa at chemaxon.com
Wed Aug 19 07:21:00 EDT 2009
Excuse cross postings.
We have added 2 new presentations to the Program for ChemAxon US UGM
next month:
* Yvonne Martin of Martin Consulting: "Tautomers: A Rant"
* Patrick Walters of Vertex Pharmaceuticals: "ASAP - Emphasizing
Multidimensional Drug Discovery"
We also update on GlaxoSmithKline's presentation which will be "SOA at
GSK - Working in a Mixed Technology Environment"
To see the complete meeting program please visit this link
<http://www.chemaxon.com/UGM/09/US/program.html,>. To see the developer
and end user training day program (preceding the meeting) see this link
<http://www.chemaxon.com/training/UGM0914.html>.
Meeting details and signup are below.
I hope you can join us.
Alex
*Event details*
US UGM: September 15-16. Developer and end user training: September 14.
Location: Catamaran Resort Hotel & Spa, San Diego, CA
* UGM page, links to registration:
http://www.chemaxon.com/UGM/09/US/index.html
* Archives of previous meetings, includes original presentations and
meeting reports from Yvonne Martin and Wendy Warr:
http://www.chemaxon.com/UGM/ugm_land.html
*Confirmed guest speakers:*
Isabella Haight - Abbott Laboratories
Kirsten Blumeyer - Celgene
Hongzhou Zhang - Eli Lilly and Co.
Yingyao Zhou - Genomics Institute of the Novartis Research Foundation
TBA - GlaxoSmithKline
John McNeil - John McNeil & Co
Tianhong Zhang - Pfizer
Craig Martin - SkunkWerks Software
Yvonne Martin - Martin Consulting
Nicholas Goncharoff - SureChem
Tobias Kind - UC Davis Genome Center - Metabolomics
Craig Knox - University of Alberta
Oleg Ursu - University of New Mexico
Patrick Walters - Vertex Pharmaceuticals
ChemAxon Partners participants (tbc) - see partner listing
<http://www.chemaxon.com/partners/integrators.html>:
*Alex Allardyce*
Marketing Dir.
*ChemAxon* *Ltd*.
Maramaros koz 3/A, Budapest, 1037, Hungary
Tel: +361 453 0435
skype: alex_allardyce
More information about the Molvis-list
mailing list